PG-201

N/A

Report date: 2025/07/07 17:53:02

Base Information

Drug NamePG-201
Drug Alias NameLaylaPG-201
ClassificationNatural product/Extract
Mechanisms of ActionInterleukin-1 beta inhibitorsTumor necrosis factor α inhibitors
TargetsTumor necrosis factor αInterleukin-1 beta
Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis
Global Approved IndicationsOsteoarthritis
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2012/01/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesViromed
China Registration ClassN/A

Develop Information

Active CompaniesPmg Pharm Co Ltd
Inactive CompaniesHelixmith Co Ltd
Active IndicationsOsteoarthritis
Inactive IndicationsOsteoarthritis, Knee

Other Information

ATC CodeM05
Related LinksN/A